GLP-1 Weight Loss Clinics in Murfreesboro, Tennessee
Browse available GLP-1 clinics in Murfreesboro offering semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and medically-supervised weight loss programs. Compare pricing, insurance, and physician credentials before you book.
No clinics listed in Murfreesboro yet
We're adding clinics daily. Check back soon, or browse all Tennessee GLP-1 clinics.
GLP-1 Clinics in Murfreesboro — FAQ
How many GLP-1 clinics are in Murfreesboro?
FindGLP1Clinic.com lists multiple GLP-1 weight loss clinics in Murfreesboro, Tennessee. This includes physician-supervised programs, med spas offering semaglutide, and telehealth providers that serve the area. New clinics are added weekly.
How much does semaglutide cost in Murfreesboro?
GLP-1 treatment in Murfreesboro typically costs $150–$600 per month. Brand-name Wegovy and Ozempic are on the higher end ($800–$1,300/month without insurance). Compounded semaglutide — available at many Murfreesboro clinics — runs $150–$350/month. Many clinics bundle the initial consultation into the first month's cost.
Does insurance cover Ozempic or Wegovy in Tennessee?
Coverage varies. Some commercial plans cover Wegovy for obesity (BMI ≥30 or ≥27 with a comorbidity) when prescribed by a physician. Ozempic is primarily covered for type 2 diabetes — weight loss coverage is narrower. Tennessee Medicaid coverage depends on your specific plan. The best way to know: call the clinics that list "Insurance Accepted" and ask them to verify your specific plan.
Can I start GLP-1 treatment via telehealth in Murfreesboro?
Yes — several GLP-1 providers serving Murfreesboro offer fully virtual consultations. You can get a prescription for semaglutide or tirzepatide without an in-person visit, with medication shipped directly to you. Look for the Telehealth badge on listings above. Note: some telehealth providers don't accept insurance, so compare options carefully.
What's the difference between semaglutide and tirzepatide?
Both are GLP-1 receptor agonists that reduce appetite and promote weight loss. Semaglutide (Wegovy, Ozempic) targets the GLP-1 receptor only. Tirzepatide (Mounjaro, Zepbound) targets both GLP-1 and GIP receptors, which tends to produce slightly more weight loss on average (around 20–22% vs. 14–16% for semaglutide). Cost and insurance coverage differ — tirzepatide is newer and often harder to get covered.